Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
130 hedge funds and large institutions have $341M invested in Sucampo Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 22 closing their positions.
132% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 28
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
21% more capital invested
Capital invested by funds: $281M → $341M (+$60.3M)
4% more funds holding
Funds holding: 125 → 130 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less call options, than puts
Call options by funds: $678K | Put options by funds: $696K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$17.5M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$14.2M |
| 3 |
Daiwa Securities Group
Tokyo,
Japan
|
+$8.03M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7.81M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$10.9M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7M |
| 4 |
Millennium Management
New York
|
-$5.43M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.84M |
SCMP Hedge Fund Activity: Q2 2015 in Review
130 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2015, worth a combined $341M — up 21% from $281M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SCMP positions and 22 closed out — a net gain of 5 holders — while 65 added to existing stakes and 28 trimmed.
The largest buyer was Invesco, adding an estimated $17.5M. The largest seller was Visium Asset Management, exiting entirely with an estimated $10.9M sold.
- 130 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2015, up from 125 in Q1 2015.
- Funds reported $341M of Sucampo Pharmaceuticals, Inc. stock for Q2 2015, up 21% quarter-over-quarter.
- 27 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2015 and 22 closed out, a net change of +5 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q2 2015 was Invesco, an estimated $17.5M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q2 2015 was Visium Asset Management, an estimated $10.9M sold.
Based on aggregated 13F filings for Q2 2015.